Document is current
Any future updates will be listed below
-
Authors
Wei, Bingyan https://orcid.org/0000-0002-1782-0860
Zhang, Tao https://orcid.org/0000-0003-3287-4629
Wang, Pengyu https://orcid.org/0000-0002-4475-2381
Pan, Yihui https://orcid.org/0000-0002-4100-7204
Li, Jiahui https://orcid.org/0000-0002-9331-031X
Chen, Weizhong https://orcid.org/0000-0002-0560-532X
Zhang, Min https://orcid.org/0000-0002-4467-618X
Ji, Quanjiang https://orcid.org/0000-0002-2321-8462
Wu, Wenjuan https://orcid.org/0000-0002-5161-3179
Lan, Lefu https://orcid.org/0000-0002-5551-5496
Gan, Jianhua https://orcid.org/0000-0002-8438-8852
Yang, Cai-Guang https://orcid.org/0000-0001-5778-4422
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (22107109, 22037007, 81861138046, 21725801)
- License Information
-
More Information
Article History
Received: 12 April 2022
Accepted: 7 November 2022
First Online: 14 November 2022
Competing interests
: B.W., T.Z., P.W., and C.-G.Y. are named inventors of pending patent application (CN202210377247.X, to the Chinese Patent Office) related to the work described. Patent applicant is Shanghai Institute of Materia Medica, Chinese Academy of Sciences. The status of application is official filing. The structures of ZG180, (<i>R</i>)- and (<i>S</i>)-ZG197 are covered in patent application. The remaining authors declare no competing interests.
: The protocols of murine skin infection experiments were reviewed and approved by the Institutional Animal Care and Use Committee (IACUC) of Shanghai Public Health Clinical Center. Experiments were performed in accordance with the relevant ethical guidelines and regulations. The laboratory animal usage license (SYXK-HU-2015-0027) is certified by Shanghai Committee of Science and Technology.
